Barpanda A - Search Results

1

A multi-subunit autophagic capture complex facilitates degradation of ER stalled MHC-I in pancreatic cancer.

Berquez M, Li AL, Luy MA, Venida AC, O'Loughlin T, Rademaker G, Barpanda A, Hu J, Yano J, Wiita A, Gilbert LA, Bruno PM, Perera RM. Berquez M, et al. Among authors: barpanda a. bioRxiv [Preprint]. 2024 Oct 29:2024.10.27.620516. doi: 10.1101/2024.10.27.620516. bioRxiv. 2024. PMID: 39554122 Free PMC article. Preprint.

2

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.

Kasap C, Izgutdina A, Patiño-Escobar B, Kang A, Chilakapati N, Akagi N, Johnson H, Rashid T, Werner J, Barpanda A, Geng H, Lin YT, Rampersaud S, Gil-Alós D, Sobh A, Dupéré-Richer D, Wicaksono G, Kawehi Kelii KM, Dalal R, Ramos E, Vijayanarayanan A, Salangsang F, Phojanakong P, Serrano JAC, Zakraoui O, Tariq I, Steri V, Shanmugam M, Boise LH, Kortemme T, Stieglitz E, Licht JD, Karlon WJ, Barwick BG, Wiita AP. Kasap C, et al. Among authors: barpanda a. bioRxiv [Preprint]. 2024 Feb 28:2024.02.24.581875. doi: 10.1101/2024.02.24.581875. bioRxiv. 2024. PMID: 38463958 Free PMC article. Preprint.

3

Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens.

Kwok DW, Stevers NO, Nejo T, Chen LH, Etxeberria I, Jung J, Okada K, Cove MC, Lakshmanachetty S, Gallus M, Barpanda A, Hong C, Chan GKL, Wu SH, Ramos E, Yamamichi A, Liu J, Watchmaker P, Ogino H, Saijo A, Du A, Grishanina N, Woo J, Diaz A, Chang SM, Phillips JJ, Wiita AP, Klebanoff CA, Costello JF, Okada H. Kwok DW, et al. Among authors: barpanda a. bioRxiv [Preprint]. 2023 Oct 20:2023.10.19.563178. doi: 10.1101/2023.10.19.563178. bioRxiv. 2023. PMID: 37904942 Free PMC article. Preprint.

4

Integrated Meta-Omics Analysis Unveils the Pathways Modulating Tumorigenesis and Proliferation in High-Grade Meningioma.

Biswas D, Halder A, Barpanda A, Ghosh S, Chauhan A, Bhat L, Epari S, Shetty P, Moiyadi A, Ball GR, Srivastava S. Biswas D, et al. Among authors: barpanda a. Cells. 2023 Oct 18;12(20):2483. doi: 10.3390/cells12202483. Cells. 2023. PMID: 37887327 Free PMC article.

5

Proteomic Investigation of COVID-19 Severity During the Tsunamic Second Wave in Mumbai.

Rajoria S, Nair D, Suvarna K, Pai MGJ, Salkar A, Palanivel V, Verma A, Barpanda A, Awasthi G, Doshi H, Dhara V, Burli A, Agrawal S, Shrivastav O, Shastri J, Srivastava S. Rajoria S, et al. Among authors: barpanda a. Adv Exp Med Biol. 2023;1412:175-195. doi: 10.1007/978-3-031-28012-2_9. Adv Exp Med Biol. 2023. PMID: 37378767

6

Integrative Proteomic and Pharmacological Analysis of Colon Cancer Reveals the Classical Lipogenic Pathway with Prognostic and Therapeutic Opportunities.

Barpanda A, Biswas D, Verma A, Parihari S, Singh A, Kapoor S, Kantharia C, Srivastava S. Barpanda A, et al. J Proteome Res. 2023 Mar 3;22(3):871-884. doi: 10.1021/acs.jproteome.2c00646. Epub 2023 Feb 2. J Proteome Res. 2023. PMID: 36731020

7

Colon Adenocarcinoma Quantitative Proteomics Reveals Dysregulation in Key Cancer Signaling Pathways and a Candidate Protein Marker Panel.

Barpanda A, Halder A, Dhote A, Parihari S, Kantharia C, Srivastava S. Barpanda A, et al. OMICS. 2023 Feb;27(2):75-85. doi: 10.1089/omi.2022.0169. Epub 2023 Feb 1. OMICS. 2023. PMID: 36730729

8

The First Pituitary Proteome Landscape From Matched Anterior and Posterior Lobes for a Better Understanding of the Pituitary Gland.

Banerjee A, Biswas D, Barpanda A, Halder A, Sibal S, Kattimani R, Shah A, Mahadevan A, Goel A, Srivastava S. Banerjee A, et al. Among authors: barpanda a. Mol Cell Proteomics. 2023 Jan;22(1):100478. doi: 10.1016/j.mcpro.2022.100478. Epub 2022 Dec 5. Mol Cell Proteomics. 2023. PMID: 36470533 Free PMC article.

9

A protein microarray-based serum proteomic investigation reveals distinct autoantibody signature in colorectal cancer.

Barpanda A, Tuckley C, Ray A, Banerjee A, Duttagupta SP, Kantharia C, Srivastava S. Barpanda A, et al. Proteomics Clin Appl. 2023 Mar;17(2):e2200062. doi: 10.1002/prca.202200062. Epub 2022 Nov 29. Proteomics Clin Appl. 2023. PMID: 36408811

10

Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays.

Banerjee A, Ray A, Barpanda A, Dash A, Gupta I, Nissa MU, Zhu H, Shah A, Duttagupta SP, Goel A, Srivastava S. Banerjee A, et al. Among authors: barpanda a. Proteomics Clin Appl. 2022 Nov;16(6):e2100111. doi: 10.1002/prca.202100111. Epub 2022 Sep 18. Proteomics Clin Appl. 2022. PMID: 35939377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters